Comments
Vivimed Labs has informed the exchanges that following approval from the Foreign Investment Promotion Board, it has issued five lakh warrants with an option to apply for and be allotted an equivalent number of equity shares, to Kitara PIIN 1102, Mauritius. The proposed issuance of warrants is to be made at an issue price of ₹315 a warrant. The FDI inflow by the foreign investor is expected to be ₹15.75 crore approximately, said Vivimed Labs. The stock of Vivimed Labs slumped 20 per cent at ₹204.85 on the NSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.